Editing Clozapine (section)

=== Economics ===
Despite the expense of the risk monitoring and management systems required, clozapine use is highly cost effective, with a number of studies suggesting savings of tens of thousands of dollars per patient per year compared to other antipsychotics, as well as advantages regarding improvements in quality of life.<ref>{{cite journal | vauthors = Oh PI, Iskedjian M, Addis A, Lanctôt K, Einarson TR | title = Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis | journal = The Canadian Journal of Clinical Pharmacology | volume = 8 | issue = 4 | pages = 199–206 | date = 2001 | pmid = 11743592 }}</ref><ref>{{cite journal | vauthors = Jin H, Tappenden P, MacCabe JH, Robinson S, Byford S | title = Evaluation of the Cost-effectiveness of Services for Schizophrenia in the UK Across the Entire Care Pathway in a Single Whole-Disease Model | journal = JAMA Network Open | volume = 3 | issue = 5 | pages = e205888 | date = May 2020 | pmid = 32459356 | pmc = 7254180 | doi = 10.1001/jamanetworkopen.2020.5888 }}</ref><ref>{{cite journal | vauthors = Morris S, Hogan T, McGuire A | title = The cost-effectiveness of clozapine: a survey of the literature | journal = Clinical Drug Investigation | volume = 15 | issue = 2 | pages = 137–152 | date = 1998 | pmid = 18370477 | doi = 10.2165/00044011-199815020-00007 | s2cid = 33530440 }}</ref> Clozapine is available as a [[generic medication]].<ref name="AHFS2015">{{cite web|title=Clozapine|url=https://www.drugs.com/monograph/clozapine.html|url-status=live|archive-url=https://web.archive.org/web/20151208103801/http://www.drugs.com/monograph/clozapine.html|archive-date=8 December 2015|access-date=1 December 2015|publisher=The American Society of Health-System Pharmacists}}</ref>